ClorDiSys to be Presenting at the 2022 AAMI eXchange

ClorDiSys is proud to announce participation in the 2022 AAMI eXchange taking place this June in San Antonio.  This conference brings together professionals in the medical device industry to discuss new technologies and best practices.  ClorDiSys will be exhibiting at booth 731 and are presenting their chlorine dioxide gas sterilization technology.  ClorDiSys is registered with the United States Food and Drug Administration (FDA) as a contract sterilizer of medical devices.  This breakthrough advancement for the medical industry was awarded to ClorDiSys Solutions, Inc, headquartered in Branchburg, NJ (registration number 3013115071).  ClorDiSys utilizes chlorine dioxide gas, which is a non-carcinogenic, United States Environmental Protection Agency (EPA), registered sterilant.  It is seen as a prudent alternative to ethylene oxide as it retains the strong sterilization benefits, yet lacks the environmental and health concerns.  Another advantage of the chlorine dioxide sterilization approach is the ability to sterilize devices containing embedded batteries.  Previous methods, such as ethylene oxide, typically do not allow for the sterilization of such devices due to the explosivity of the gas posing a potential danger when interacting with one another.  ClorDiSys also manufactures chlorine dioxide sterilization chambers in sizes ranging from less than a pallet, to 4-pallet capacity, with larger sizes in development.  These are easily implemented in a manufacturer’s location due to the affordability and lack of special construction necessary to implement it.

During AAMI eXchange, ClorDiSys will be presenting an in-depth discussion of the sterilization chambers in Product Theater 1 on Saturday June 4^th from 2:30-2:50pm. On Sunday June 5^th, -ClorDiSys will be presenting as part of the Sterilization Track education sessions “Advantages of Chlorine Dioxide over Ethylene Oxide” from 9:15-10:15am. 

______________________________________________________________________________

Established in 2001, ClorDiSys Solutions, Inc is a New Jersey based business that manufactures sterilization and disinfection equipment and provides decontamination services.  ClorDiSys developed its technology through Johnson and Johnson, and chlorine dioxide gas has been providing true sterilization for medical devices for over 25 years on items such as suture products, artificial joints, and implantable contact lenses.